Tyrphostins .5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: Structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins

被引:248
|
作者
Gazit, A
App, H
McMahon, G
Chen, J
Levitzki, A
Bohmer, FD
机构
[1] HEBREW UNIV JERUSALEM,ALEXANDER SILBERMAN INST LIFE SCI,DEPT BIOL CHEM,JERUSALEM,ISRAEL
[2] SUGEN INC,REDWOOD CITY,CA 94063
[3] UNIV JENA,GROWTH FACTOR SIGNAL TRANSDUCT MED FAC,MAX PLANCK SOC,RES GRP,D-07747 JENA,GERMANY
关键词
D O I
10.1021/jm950727b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 3-indoleacrylonitrile tyrphostins, 2-chloro-3-phenylquinolines, and 3-arylquinoxalines were prepared and tested for inhibition of platelet-derived growth factor receptor tyrosine kinase (PDGF-RTK) activity. The potency of the inhibitors was found to be quinoxalines > quinolines > indoles. Lipophilic groups (methyl, methoxy) in the 6 and 7 positions and phenyl at the 3 position of quinoxalines and quinolines were essential for potency, in contrast to the hydrophilic catechol group in tyrphostins active against EGFR kinase inhibition at different sites. The inhibitors showed selectivity for PDGF and were not active against EGF receptor and HER-2/c-ErbB-2 receptor.
引用
收藏
页码:2170 / 2177
页数:8
相关论文
共 50 条
  • [21] Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity
    Dietmar Gross
    Günther Bernhardt
    Armin Buschauer
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 589 - 599
  • [22] Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity
    Gross, Dietmar
    Bernhardt, Gunther
    Buschauer, Armin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (09) : 589 - 599
  • [23] Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines.
    Gibson, KH
    Grundy, W
    Godfrey, AA
    Woodburn, JR
    Ashton, SE
    Curry, BJ
    Scarlett, L
    Barker, AJ
    Brown, DS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (21) : 2723 - 2728
  • [24] Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: Tyrosine kinase inhibitors as a potential therapy
    Savikko, J
    Taskinen, E
    von Willebrand, E
    TRANSPLANTATION, 2003, 75 (08) : 1147 - 1153
  • [25] Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
    Criscitiello, Carmen
    Gelao, Lucia
    Viale, Giulia
    Esposito, Angela
    Curigliano, Giuseppe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 599 - 610
  • [26] Inhibitors of the epidermal growth factor receptor protein tyrosine kinase: A quantitative structure-activity relationship analysis
    Singh, P
    Kumar, R
    JOURNAL OF ENZYME INHIBITION, 1998, 13 (02): : 125 - 134
  • [27] The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor α
    Miyake, S
    Lupher, ML
    Druker, B
    Band, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 7927 - 7932
  • [28] Small molecule inhibitors of the platelet-derived growth factor receptor, the fibroblast growth factor receptor, and Src family tyrosine kinases
    Showalter, HDH
    Kraker, AJ
    PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) : 55 - 71
  • [29] Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors
    Hennequin, LF
    Thomas, AP
    Johnstone, C
    Stokes, ESE
    Plé, PA
    Lohmann, JJM
    Ogilvie, DJ
    Dukes, M
    Wedge, SR
    Curwen, JO
    Kendrew, J
    Lambert-van der Brempt, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5369 - 5389
  • [30] SUPPRESSION OF PLATELET-DERIVED GROWTH-FACTOR RECEPTOR TYROSINE KINASE-ACTIVITY BY UNSATURATED FATTY-ACIDS
    TOMASKA, L
    RESNICK, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (07) : 5317 - 5322